RE:RE:RE:Is a 25% No Response rate inevitable ?I hear you and have an equally jaded view of the cancer industry. But I'm good either way.
Cancer cases are through the roof and only going higher with COVID, which is proven to cause a lot of (sometimes very aggressive) cancer in both young and old. There's no profit in endless waiting lists where people don't even get treated. Unfortunately, I don't see a shortage of work/income for cancer-treating urologists any time soon. I can't imagine urologists twiddling their thumbs for lack of work because Theralase came along - probably just the opposite because more people will see the ease and effectiveness of the treatment and choose to get it sooner. And don't forget that TLT's treatment is easily repeated for stubborn or return cancers.
Nevertheless...show me the MONEY,